e-learning
resources
Paris 2018
Monday, 17.09.2018
Respiratory medicine meets hematology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Graft-versus-host disease in the lungs: novel insights and treatments
A. Bergeron Lafaurie (Paris, France)
Source:
International Congress 2018 – Respiratory medicine meets hematology
Session:
Respiratory medicine meets hematology
Session type:
Symposium
Number:
2116
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Bergeron Lafaurie (Paris, France). Graft-versus-host disease in the lungs: novel insights and treatments. International Congress 2018 – Respiratory medicine meets hematology
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Monitoring of pulmonary function in Pompe disease: a muscle disease with new therapeutic perspectives
Source: Eur Respir J 2005; 26: 984-985
Year: 2005
Amyloid-and nonamyloid-deposition disease in the lung: novel manifestations
Source: Annual Congress 2013 –Ceremony for ERS Award for Rare Pulmonary Disease (financially supported by GlaxoSmithKline) followed by Symposium: Autoimmunity and lung diseases in humans
Year: 2013
Interstitial lung disease: new challenges and evolving phenotypes
Source: Eur Respir Rev 2009; 19: 91-93
Year: 2010
Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease
Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019
Year: 2020
Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities
Source: Eur Respir J 2014; 44: 513-522
Year: 2014
Defining severe obstructive lung disease in the biologic era: an endotype-based approach
Source: Eur Respir J, 54 (5) 1900108; 10.1183/13993003.00108-2019
Year: 2019
The link between inflammation and lung cancer: lessons from chronic obstructive pulmonary disease
Source: International Congress 2018 – Scientific Year in Review
Year: 2018
Pulmonary Lymphangiomatosis – insights into an ultra-rare disease
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018
Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications
Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD
Year: 2009
Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer?
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Cleaning agents and chronic lung disease: does the evidence support a link with COPD?
Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health?
Year: 2018
Introduction: systemic effects in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 1S
Year: 2003
Erdheim-Chester disease: Patterns and pulmonary involvement
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Implication of microRNA-148b in chronic obstructive lung disease of betaENaC-overexpressing mice
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Lymphangiogenesis in chronic obstructive pulmonary disease (COPD): New insights in airways remodeling
Source: Annual Congress 2010 - Airways and lung mechanics in subjects of all ages
Year: 2010
Novel insights into the genetics of smoking behaviour, lung function and chronic obstructive pulmonary disease in UK Biobank
Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept